Murray praises bipartisan deal to cap insulin at $35 a month for patients
Senator Murray: “This is life and death for patients. So let’s get this done, save families some money, and most importantly save lives.”
(Washington, DC) – Today, U.S. Senator Patty Murray (D-WA), Chair of the Health, Education, Labor, and Pensions Committee, released the following statement on the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act—a bipartisan bill Senators Shaheen (D-NH) and Collins (R-ME) announced today that would lower insulin costs by capping patients’ costs at $35 a month, and encouraging manufacturers to reduce list prices.
“People are risking their lives and rationing their insulin because the cost of this lifesaving drug is so out of control. We have to bring down prices for the essentials—and for millions and millions of patients, insulin is absolutely essential. This is life and death for people. So let’s get this done, save families some money, and most importantly save lives,” said Senator Murray. “I appreciate the leadership of Senator Shaheen, Senator Collins, and Senator Warnock who have all been focused on this issue, and look forward to working with them to get this deal signed into law.”
PDF of the full text of the INUSLIN Act available HERE.